The AR promoter in the MDA PCa PDX models shows silencing histone modifications (H3K27me3 and H3K9me2); moreover, EZH2 inhibition with 3-deazaneplanocin A induces AR expression and growth inhibition in the AR-negative MDA PCa PDX models [155]. This evidence concerns the gene EZH2 and posterior cortical atrophy.